Sign in
Not yet taking people in United StatesNo phase

The EYERISING Study

Key facts

Who runs it
University of Wisconsin, Madison
Where
Madison, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Status
Not yet recruiting
People taking part
333 people, planned
Starts
Dec 2026
Expected to end
May 2029
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Repeated Low-Level Red Light (RLRL) therapy
  • Placebo Device
Record updated
5 November 2026

Who can take part

Age
6 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age ≥ 6 and ≤ 12 (at screening)
  • Myopia: Cycloplegic SER -1.0 to -7.0 D
  • Astigmatism: < 1.5 D
  • Anisometropia: < 1.5 D
  • Informed parental consent
  • Consistent access to wireless internet

Who cannot take part

  • A subject who is born female and who is currently menstruating or has begun menstruation (menarche); Ophthalmic diseases, conditions, or syndromes other than refractive errors; Previous use of treatment for myopia control (e.g., defocusing lenses or contact lenses, orthokeratology, atropine, and pirenzepine); Any previous ocular surgery; Systemic diseases (e.g., endocrine, cardiac diseases) and developmental anomalies; Inability to attend regular follow up visits; Participants with any symptom, disease, or other condition that, in the opinion of the investigators, may affect the effectiveness of the investigational treatment and/or the ability of the participant to complete study activities

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 6 and 12 years old?

Where in United States

Also in 1 other country, 1 site

  • University of Wisconsin - MadisonMadison, United StatesContact: Angie AdlerNot yet recruiting

About the trial

What the trial wants to find out

The purpose of this clinical trial is to see if and how well Repeated Low-Level Red Light (RLRL) therapy works to control myopia over 12 months. The main question it aims to answer is:

Read full original descriptionShow less

* Can RLRL therapy help slow down the worsening of myopia?

Participants will use a red-light therapy investigational device at home, 5 days a week for 12 months.

The 2 groups in the trial

  • Red light therapyTreatment being tested

    Participants will receive red light therapy

    Treatment: Repeated Low-Level Red Light (RLRL) therapy

  • PlaceboPlacebo, for comparison

    Participants will receive placebo therapy

    Treatment: Placebo Device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Repeated Low-level Red Light for Myopia Progression Study: An International, Multicenter, Multiethnic, Randomized Controlled Trial, IPOSC Study
Criteria questions
Built from NCT07909720, who can take part
Record updated
5 November 2026